GO
Loading...

Acquisitions

More

  • *Pfizer works on next move in takeover bid for Astrazeneca. Leading the Nasdaq down was Amazon.com, which extended Friday's sharp drop a day after its earnings report. Shares of Pfizer gained 4.2 percent to $32.04 after the U.S. drugmaker was said to be working on its next move in a potential bid to take over Britain's AstraZeneca Plc.

  • *Pfizer works on next move in takeover bid for Astrazeneca. Leading the Nasdaq down was Amazon.com, which extended Friday's sharp decline a day after its earnings report.

  • NEW YORK, April 28- Shares of AstraZeneca surged on Monday after a takeover offer, lifting global equity markets on speculation of further corporate deal-making, while crude oil prices fell on increased U.S. sanctions against Russia over the Ukraine crisis.

  • *Comcast aims to win regulatory approval for Time Warner Cable deal. April 28- Comcast Corp offered to sell 1.4 million pay TV subscribers to Charter Communications Inc for $7.3 billion as part of a transaction aimed at winning regulatory approval for its proposed $45 billion takeover of Time Warner Cable.

  • STOCKHOLM, April 28- Swedish drugmaker Meda rejected an improved takeover offer from U.S. generics firm Mylan which one person familiar with the matter said valued Meda at around $9 billion including debt, driving its shares sharply back down.

  • *Comcast aims to win regulatory approval for Time Warner Cable deal. April 28- Comcast Corp offered to sell 1.4 million pay TV subscribers to Charter Communications Inc for $7.3 billion, as part of a wider transaction aimed at winning regulatory approval for its proposed $45 billion takeover of Time Warner Cable.

  • UPDATE 1-Meda board rejects new Mylan offer Monday, 28 Apr 2014 | 2:50 AM ET

    STOCKHOLM, April 28- Swedish drugmaker Meda has rejected an improved takeover offer from U.S. generics firm Mylan, saying it was confident in its future as an independent company and its biggest shareholder did not support the bid.

  • UPDATE 1-Pfizer confirms desire to buy AstraZeneca Monday, 28 Apr 2014 | 2:28 AM ET

    LONDON, April 28- U.S. drugmaker Pfizer made a bid approach to AstraZeneca in January and contacted its British rival again on April 26 seeking to renew discussions about a takeover, the U.S. firm said on Monday. A Pfizer bid for AstraZeneca would be one of the largest ever pharmaceuticals deals.

  • April 27- German drugmaker Bayer AG is exploring the sale of its $10 billion plastics unit to focus on growing its health business, Bloomberg reported citing people with knowledge of the matter.

  • April 25- Prestige Brands Holdings Inc, a marketer and distributor of healthcare and cleaning products, said it would buy rival Insight Pharmaceuticals Corp for $750 million in cash to expand its range of feminine care products.

  • April 24- Zimmer Holdings Inc said on Thursday it would buy rival orthopedic products maker Biomet Inc for more than $13 billion, the latest deal in a wave of consolidations in the healthcare industry. The deal is expected to take Zimmer from the fourth-largest seller of orthopedics products to No. 2, behind Johnson& Johnson.

  • NEW DELHI, April 24- Nokia said that due to an ongoing tax dispute its Indian mobile phone handset plant was unlikely to be included in a deal due to be concluded on Friday for the sale of its global handset business to Microsoft.

  • GE in talks to buy Alstom: Report     Thursday, 24 Apr 2014 | 6:09 AM ET

    Nicholas Heyman, William Blair, discusses General Electric's possible acquisition of French train and power plant builder Alstom for more than $13 billion.

  • Facebook gets U.S. antitrust approval to buy Oculus Wednesday, 23 Apr 2014 | 11:09 AM ET

    WASHINGTON, April 23- Social network giant Facebook Inc has won U.S. antitrust approval to buy Oculus VR Inc, a two-year-old maker of virtual reality goggles, the Federal Trade Commission said on Wednesday. Facebook said on March 25 that it planned to buy Oculus for $2 billion in its first-ever hardware deal.

  • BANGKOK, April 23- PTT Exploration and Production Pcl, Thailand's top oil and gas explorer, has bought Hess Corp's assets in Thailand in a $1 billion deal as part of its attempt to boost its gas business, the company's CEO said on Wednesday.

  • Goldman buys Westpeak in drive for 'smart beta' assets Tuesday, 22 Apr 2014 | 5:15 PM ET

    NEW YORK, April 22- Goldman Sachs Group Inc's asset-management business has agreed to buy Westpeak Global Advisors, a firm that aims to beat market indexes by using factors other than company size to pick stock investments.

  • Einhorn's new course     Tuesday, 22 Apr 2014 | 2:31 PM ET

    Sandy Villere, Villere Funds, shares his thoughts on Greenlight Capital's new stake in Conn's.

  • *Novartis to buy GSK's oncology assets for $14.5 bln. The deals, which include Novartis buying GSK's cancer drugs and GSK acquiring Novartis' vaccines business, came hot on the heels of a newspaper report that AstraZeneca had turned down a $101 billion bid approach from Pfizer- a story that sent shares across the sector surging.

  • April 22- Canada's Valeant Pharmaceuticals International Inc said on Tuesday it has offered to buy Botox maker Allergan Inc for roughly $47 billion in a move to expand its skin and eye-care portfolio. Bill Ackman's Pershing Square, Allergan's largest shareholder with a 9.7 percent stake, disclosed in a filing on Monday that it is supporting the bid.

  • Eli Lilly Chairman & CEO John Lechleiter discusses his business' expansion of its animal health unit with the acquisition of Novartis' animal health business.